In our research, based on comprehensive examination and identification, aging-related MS4A6A is not only able to accurately predict an unfavorable prognosis of glioma but is also associated with malignant features, such as IDH status, 1p19q status, and WHO grade. Here, IDH2 is linked to central nervous system cancer.